FEUZ Performance — First Trust Eurozone AlphaDEX ETF
Data updated: 2026-08-21
FEUZ returned +9.84% year to date and +24.09% over one year to Jun 2026. Annualised returns are +21.99% over 3 years and +10.54% over 5 years. The fund beat its Europe Equity category average: $100 invested three years ago grew to $182, against $151 for the category, and to $124 over one year, against $114. Volatility over the past three years was 15.36% a year. In the 12 months to Jun 2026 the fund took in a net $57.9M, and assets reached $136.06M.
FEUZ Growth of $100
What $100 invested in First Trust Eurozone AlphaDEX ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.
| Period | FEUZ | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $124 | $114 |
| 3 years (Jul 2023 – Jun 2026) | $182 | $151 |
| 5 years (Jul 2021 – Jun 2026) | $165 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $205 | $183 |
FEUZ Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.84% |
| 1 year | +24.09% |
| 3 years (annualised) | +21.99% |
| 5 years (annualised) | +10.54% |
FEUZ Annual Returns
Calendar-year total returns of First Trust Eurozone AlphaDEX ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +9.84% |
| 2025 | +56.56% |
| 2024 | +1.88% |
| 2023 | +15.72% |
| 2022 | −19.65% |
| 2021 | +12.92% |
| 2020 | +4.69% |
| 2019 (Jul–Dec) | +6.48% |
FEUZ Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.4% | +4.7% | −7.6% | +7.6% | +2.6% | −2.3% | — | — | — | — | — | — |
| 2025 | +5.5% | +5.6% | +3.3% | +5.6% | +8.8% | +4.9% | +0.3% | +3.6% | +2.8% | −0.5% | +2.0% | +4.3% |
| 2024 | −1.5% | +1.4% | +5.1% | −1.3% | +6.6% | −6.7% | +4.1% | +1.5% | +1.0% | −3.6% | −2.5% | −1.4% |
| 2023 | +10.7% | −1.2% | −0.8% | +1.6% | −5.7% | +7.5% | +4.0% | −3.7% | −4.9% | −5.2% | +10.9% | +3.6% |
| 2022 | −2.9% | −6.5% | −1.7% | −7.2% | +4.2% | −13.0% | +2.2% | −5.6% | −10.3% | +10.0% | +12.2% | +0.1% |
| 2021 | −0.3% | +2.1% | +4.1% | +3.7% | +5.4% | −3.7% | +1.9% | +2.8% | −4.8% | +2.4% | −5.1% | +4.5% |
| 2020 | −3.3% | −7.4% | −21.3% | +7.4% | +7.0% | +3.6% | +4.2% | +6.3% | −3.0% | −5.9% | +18.1% | +4.5% |
| 2019 | — | — | — | — | — | — | −2.4% | −2.5% | +3.2% | +4.0% | +1.7% | +2.6% |
FEUZ Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.36%
- 3-year Sharpe ratio: 1.14 (vs 4.5% risk-free rate)
- Best month: +10.88% (Nov 2023)
- Worst month: −7.64% (Mar 2026)
FEUZ Fund Flows
Monthly money in and out of First Trust Eurozone AlphaDEX ETF, from SEC Form N-PORT.
- 12-month net flow: $57.9M
- 12-month gross sales (incl. reinvestments): $77.8M
- Sales ÷ redemptions: 3.92×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $3.3M | −$3.3M |
| Apr 2026 | $0 | $13.4M | −$13.4M |
| Mar 2026 | $3.1M | $3.1M | −$54K |
| Feb 2026 | $26.4M | $0 | $26.4M |
| Jan 2026 | $25.2M | $0 | $25.2M |
| Dec 2025 | $3.1M | $0 | $3.1M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $5.8M | $0 | $5.8M |
| Aug 2025 | $5.8M | $0 | $5.8M |
| Jul 2025 | $8.5M | $0 | $8.5M |
FEUZ Assets Under Management
Net assets of First Trust Eurozone AlphaDEX ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $136.06M |
| 2026-03-31 | $143.88M |
| 2025-12-31 | $92.14M |
| 2025-09-30 | $84.82M |
| 2025-06-30 | $60.50M |
| 2025-03-31 | $44.08M |
| 2024-12-31 | $18.20M |
| 2024-09-30 | $63.59M |
| 2024-06-30 | $53.79M |
| 2024-03-31 | $16.99M |
| 2023-12-31 | $18.21M |
| 2023-09-30 | $16.81M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.